Literature DB >> 12236809

Dose-response relationship for parathyroid adenoma after exposure to ionizing radiation in infancy.

Erik Holmberg1, Arne Wallgren, Lars-Erik Holm, Marie Lundell, Per Karlsson.   

Abstract

Several authors have suggested that there is an excess risk of hyperparathyroidism, adenomas or hyperplasia after exposure to ionizing radiation. There is still, however, some uncertainty about this association, because these diseases are often asymptomatic and escape clinical detection if not specially searched for. This study is based on a pooled Swedish cohort of 27,925 persons with skin hemangiomas. The majority received radiation treatment in infancy between 1920 and 1965 in Stockholm and Gothenburg. The mean age at treatment was 6 months and the median thyroid dose was 0.20 Gy (range 0-28.5 Gy). Record linkage with the Swedish Cancer Register for the period 1958-1997 gave 43 cases of parathyroid adenoma in the cohort. Analyses of excess relative risk (ERR) models were performed using Poisson regression methods. Clinical records were scrutinized to determine if the childhood radiation exposure was known (biased cases) at the time of diagnosis. Seven of the cases of parathyroid adenoma were classified as biased cases. The standardized incidence ratio (SIR) was 2.10 (95% confidence interval 1.52-2.82) when all cases were included and 1.76 (95% CI 1.23-2.43) with the biased cases excluded. A linear dose-response model with stratification for sex fitted the data best. The ERR per gray was 3.84 (95% CI 1.56-8.99) with all cases and 1.56 (95% CI 0.36-4.45) with the biased cases excluded. There was a significant difference in the ERR per gray between the two subcohorts, probably because of different diagnostic activity in the regions. Our findings confirm that there is a dose-response relationship for radiation-induced parathyroid adenomas.

Entities:  

Mesh:

Year:  2002        PMID: 12236809     DOI: 10.1667/0033-7587(2002)158[0418:drrfpa]2.0.co;2

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  7 in total

1.  Early parathyroid hormone laboratory abnormalities related to therapeutic radiation of neck: an Egyptian experience.

Authors:  Mohamed M Aboelnaga; Engy M Aboelnaga
Journal:  Med Oncol       Date:  2015-04-23       Impact factor: 3.064

2.  Is the risk of primary hyperparathyroidism increased in patients with untreated breast cancer?

Authors:  V Belardi; E Fiore; E Giustarini; I Muller; S Sabatini; V Rosellini; E Seregni; R Agresti; C Marcocci; P Vitti; C Giani
Journal:  J Endocrinol Invest       Date:  2012-08-29       Impact factor: 4.256

Review 3.  Parathyroid cancer.

Authors:  John M Sharretts; Electron Kebebew; William F Simonds
Journal:  Semin Oncol       Date:  2010-12       Impact factor: 4.929

Review 4.  Hyperparathyroidism in the elderly patient.

Authors:  Rebecca Sims; Charanjeit Ubhi; David Hosking
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

5.  131I treatment for thyroid cancer and risk of developing primary hyperparathyroidism: a cohort study.

Authors:  Chien-Mu Lin; Pat Doyle; Yu-Tse Tsan; Chang-Hsing Lee; Jung-Der Wang; Pau-Chung Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-08-28       Impact factor: 9.236

6.  Breast cancer associated with primary hyperparathyroidism: a nested case control study.

Authors:  Sophie Norenstedt; Fredrik Granath; Anders Ekbom; Jonas Bergh; Mats Lambe; Jan Adolfsson; Fredrik Warnberg; Jan Zedenius; Inga-Lena Nilsson
Journal:  Clin Epidemiol       Date:  2011-03-25       Impact factor: 4.790

7.  Hyperparathyroidism two years after radioactive iodine therapy in an adolescent male.

Authors:  Danielle L Gomez; Dorothy I Shulman
Journal:  Case Rep Pediatr       Date:  2014-01-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.